According to the latest publicly available documents from the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Revolution Medicines has officially demanded that Erasca immediately cease all research, development, and commercial promotion activities related to its anti-cancer drug Eras-0015 within the United States.

老虎证券2026/04/27 12:44

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Yemen's Houthis vow more attacks on Saudi airports, oil facilities

FXStreet•2026/10/15 00:21

Yen slips to a three-week low on US CPI, then recovers it all

FXStreet•2026/10/15 00:15

CoreWeave Chief Revenue Officer Jonathan Jones Reports Disposal of $2.94 Million in Common Shares

Bitget•2026/10/14 23:32

Inflation surpasses expectations, impacting small-cap stocks; Russell 2000 drops nearly 2%, confirming a technical correction

On Wednesday, approximately four-fifths of the constituents in the Russell 2000 Index recorded declines. Since its peak in August, the index has dropped by 11%, falling below its 200-day moving average and entering a technical correction for the first time since March this year. Analysis indicates that with the US CPI rising more than expected and the probability of rate hikes increasing, small-cap, consumer, and transportation stocks are facing "sustained and long-term resistance."

华尔街见闻•2026/10/14 23:26